11 10, 2016 Giovanna De Maglio et al., Management optimization of non small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach. Annals of Oncology Diatech Pharmacogenetics2016-10-11T15:56:40+02:00 Read More
11 10, 2016 Annarita Destro et al., The impact of mass spectrometry multigenic platform on the management of metastatic colorectal patients. Annals of Oncology Diatech Pharmacogenetics2017-08-07T16:00:55+02:00 Read More
11 10, 2016 Elisa Chiadini et al., Frequency of driver mutations in EGFR wt NSCLC using mass spectrometry: Experience of Area Vasta Romagna. Annals of Oncology Diatech Pharmacogenetics2016-10-11T15:41:59+02:00 Read More
1 10, 2016 Daniela Furlan et al., Detection of early genetic and epigenetic alterations in NSCLC by using mass spectrometry and pyrosequencing analysis. Annals of Oncology Diatech Pharmacogenetics2016-10-01T15:32:00+02:00 Read More
31 08, 2016 Giuseppe Aprile et al., Comparison of the molecular profile of brain metastases from colorectal cancer and corresponding primary tumors. Future Oncology Diatech Pharmacogenetics2016-08-31T11:25:22+02:00 Read More
30 08, 2016 Lorenzo Gerratana et al., Real-time tests of multiple genome alterations take the first steps into the clinic: a learning example. Onco Targets and Therapy Diatech Pharmacogenetics2017-08-07T11:23:58+02:00 Read More
21 08, 2016 Roberto Moretto et al., Location of Primary Tumor and Benefit From Anti-Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer. The Oncologist Diatech Pharmacogenetics2016-08-21T11:46:30+02:00 Read More
7 07, 2016 Maria Rosaria Raspollini et al., Multiple and bilateral kidney tumors with clear cells of three different histotypes: A case report with clinicopathologic and molecular study. APMIS Diatech Pharmacogenetics2016-07-07T12:29:43+02:00 Read More
7 07, 2016 Andrea Casadei Gardini et al., Efficacy of sorafenib in BRAF-mutated non-small-cell lung cancer (NSCLC) and no response in synchronous BRAF wild type-hepatocellular carcinoma: a case report. BMC Cancer Diatech Pharmacogenetics2017-08-08T12:42:00+02:00 Read More
14 06, 2016 Riccardo Giannini et al., EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center. Oncology Reports Diatech Pharmacogenetics2017-08-08T12:43:22+02:00 Read More
